Recon: GSK, Sanofi team up for coronavirus vaccine; India to boost domestic API production

• Trump: It's my decision when to reopen US economy (Reuters) (NPR)
• NY, CA and other states plan for reopening as coronavirus crisis eases (Reuters) (NPR) (The Hill)
• White House says Trump 'is not firing Dr. Fauci' (NPR) (Reuters)
• J&J buoyed by Tylenol, branded drugs while devices struggle (Bloomberg) (CNBC) (Financial Times)
• Despite qualms, arthritis drug to be tested in coronavirus study (NYTimes)
• Retail scripts of vaccines, acute drugs decline sharply amid COVID-19 pandemic (Fierce)
• Former FDA chief grabs spotlight with coronavirus plans to ‘turn the lights back on’ (Washington Post)

• GlaxoSmithKline, Sanofi team up for coronavirus vaccine (WSJ) (Financial Times) (STAT) (Press)
• 'Mixed picture' in Europe, COVID-19 vaccine at least 12 months off: WHO (Reuters)
• AstraZeneca to test impact of cancer drug Calquence on coronavirus patients (Reuters)
• India to boost drug ingredient output to pare China reliance (STAT) (Economic Times)
• Swiss ICUs face drug bottlenecks as world scrambles for coronavirus meds (Reuters)
• Congo records third new Ebola case from same infection chain: WHO (Reuters)
• UN agencies: 117 million children may miss measles shots due to COVID-19 (Reuters) (NYTimes)
• China approves two experimental coronavirus vaccines to enter clinical trials (Reuters)
• Getting a coronavirus test in Wuhan: Fast, cheap and easy (Reuters)
• WHO chief says confident US funding will continue in COVID fight (Reuters)
• Brazilian lawmakers propose compulsory licensing for Covid-19 products (STAT)

• WHO says covid-19 immunity is an unknown; disease '10 times deadlier' than 2009 flu (NPR) (CNBC)
• Reasons for hope: the drugs, tests and tactics that may conquer coronavirus (Reuters) (GEN)
• Doctors ask for death penalty drugs to treat coronavirus patients (The Hill)
• IMF says the world will ‘very likely’ experience worst recession since the 1930s (CNBC)
• The next coronavirus testing debacle (Politico)
• G20 health ministers to speak next week about coronavirus: statement (Reuters)
• Moderna's coronavirus vaccine plan may be possible, but a lot has to go in its favor (BioPharmaDive) (Endpoints) (Fierce)
• Johns Hopkins researchers publish a how-to guidebook on Covid-19 plasma transfusions (Endpoints)
• Why a decades-old TB vaccine is getting attention in the fight against Covid-19 (STAT)
• Ford making masks to protect workers against COVID-19 (Reuters)
• Decontaminated N95 masks boost spirits of front-line hospital workers (Boston Globe)
• Pentagon awards contract for N-95 mask sterilization at 60 sites (Reuters)
• Anti-malarial drug touted by Trump was subject of CIA warning to employees (Washington Post)
• Health Minister Vows to Shorten Review Time for Avigan (Pharma Japan)
• ICMR may use remdesivir if local companies can manufacture it (Economic Times)
• South Dakota launches clinical trial of hydroxychloroquine (The Hill)
• Healios to enroll COVID-19 patients in phase II off-the-shelf cell therapy program for ARDS (Pharma Japan)
• When should coronavirus lockdowns be lifted? WHO offers advice on adapting to a ‘new normal’ (CNBC) (Reuters)
• First UN solidarity flight departs Addis Ababa carrying vital COVID-19 medical supplies to all African nations (WHO)
• US coronavirus death toll tops 23,000 - Reuters tally (Reuters)
• India extends coronavirus lockdown until May 3 (CNBC)
• Brazil likely has 12 times more coronavirus cases than official count, study finds (Reuters)
• French new coronavirus death toll rises by 574 to 14,967 (Reuters)
• UK coronavirus death toll could be far higher than previously shown (Reuters)
• UK chief adviser expects COVID deaths curve to plateau for two or three weeks (Reuters)
• Coronavirus not contained in Germany, warns institute as government weighs easing (Reuters)
• Italy's daily coronavirus cases decline, deaths rise (Reuters)

• Zai Lab targets blood cancers in deal with Regeneron (STAT)
• Biogen Alzheimer's filing likely hit by pandemic, as drugs against the disease set for delay (Fierce)
• Alnylam's vutrisiran gets fast-track treatment at the FDA (Fierce)
• FDA clears wave of foreign manufacturing plants as COVID-19 concerns continue to grow (Fierce) (Economic Times)
• Merck Bid for Second Pan-Cancer Keytruda Indication Would Raise Tumor Mutation Burden to cdx Status (Precision Oncology News)
• Was Coronavirus A Factor In US FDA Approval Of Proventil HFA First Generic? (Pink Sheet)
• Ploughing through a crowded PD-(L)1 market, Beigene loads up on promising lung cancer data (Endpoints)
• Micro-cap Mei Pharma lands $100M upfront on beleaguered PI3K pathway (Endpoints)
• Touting new way of mining neuro targets, Takeda spinout draws $45M from GV, Bill Gates, Foresite (Endpoints)
• Alnylam's new pipeline star gets on FDA fast track; ARCH-backed biotech nabs orphan drug status (Endpoints)
• SMC accepts four medicines for NHS use (PharmaTimes)
• Coronavirus impact on India's pharma sector (Economic Times)
• Drug, medical device manufacturing companies operate at 50% capacity (Economic Times)
• Pharma sector flags shortage of packaging materials, transport (Economic Times)

• Takeaways From FDA's Relaxed Rules For Making Face Masks (Law360)
• South Korea set to double supply of coronavirus tests to US (Reuters)
• Coronavirus saliva test gets FDA emergency use approval, Rutgers University says (CNBC)
• GE, Medtronic, Resmed among 7 medtechs part of $1.4B in finalized HHS ventilator contracts (MedtechDive)
• FDA quickly authorizes its 2nd blood filtering device for COVID-19 (Fierce)
• FDA EUAs go to 1st blood purifiers for COVID-19 patients, new N95 sterilizers (MedtechDive)
• The latest coronavirus shortage: hospital infusion pumps (MedtechDive)
• J&J blames pandemic for medical device sales slump (MedtechDive)

• Qualification opinion of clinically interpretable treatment effect measures based on recurrent event endpoints that allow for efficient statistical analyses (EMA)
• Coronavirus (COVID-19) Update: Daily Roundup April 13, 2020 (FDA)
• Trump’s disdain for ‘Obamacare’ could hamper virus response (AP)
• Teva Unit in Puerto Rico Settles With EPA Over Pharma Pollution (Bloomberg Law) (Law360)
• Complete Summary Judgment in Remanded Pelvic Mesh Case (Drug & Device Law)
• Where's Medicare disparity data on coronavirus? (Politico Pulse)
• US FDA Is Pulled Into Zofran Product Liability Litigation (Pink Sheet)
• Walmart Hid That It Was Under Criminal Investigation for Its Opioid Sales, Lawyers Say (ProPublica)